1 |
[cc-10004] |
- |
- |
- |
- |
097 1件: 97 💬 |
2 |
[ccx140-b] |
- |
- |
- |
- |
222 1件: 222 💬 |
3 |
Aln-cc5 |
- |
- |
- |
- |
062 3件: 62, 66, 109 💬 |
4 |
Apremilast (cc-10004) |
Apremilast |
1件: D08860 D08860 💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
056 1件: 56 💬 |
5 |
Behavioral: collaborative care (cc) |
- |
- |
- |
- |
013 1件: 13 💬 |
6 |
Candesartan plus non-ccb agents |
Candesartan |
1件: D00522 D00522 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
067 1件: 67 💬 |
7 |
Cc |
- |
- |
- |
- |
013 13件: 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 162, 202, 271 💬 |
8 |
Cc-100004 |
- |
- |
- |
- |
084 1件: 84 💬 |
9 |
Cc-10004 |
- |
- |
- |
- |
046 5件: 46, 56, 97, 162, 271 💬 |
10 |
Cc-220 |
CC-220 |
- |
- |
- |
049 2件: 49, 84 💬 |
11 |
Cc-220 0.3 mg daily |
CC-220 |
- |
- |
- |
084 1件: 84 💬 |
12 |
Cc-220 0.6mg daily |
CC-220 |
- |
- |
- |
084 1件: 84 💬 |
13 |
Cc-292 |
- |
- |
- |
- |
046 1件: 46 💬 |
14 |
Cc-4047 |
- |
- |
- |
- |
028 2件: 28, 51 💬 |
15 |
Cc-5013 |
- |
- |
- |
- |
028 2件: 28, 96 💬 |
16 |
Cc-90001 |
- |
- |
- |
- |
085 1件: 85 💬 |
17 |
Cc-930 |
- |
- |
- |
- |
085 1件: 85 💬 |
18 |
Cc100 |
- |
- |
- |
- |
002 1件: 2 💬 |
19 |
Ccd 1042 |
- |
- |
- |
- |
152 1件: 152 💬 |
20 |
Ccd 1042, md 9150000, mepalon 1042, spt316 |
- |
- |
- |
- |
152 2件: 152, 206 💬 |
21 |
Ccd 1042, md 9150000, mepalon 1042, spt3162 |
- |
- |
- |
- |
152 1件: 152 💬 |
22 |
Cci-779 |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
23 |
Ccp-020 |
- |
- |
- |
- |
036 1件: 36 💬 |
24 |
Ccp-690-550-10 |
- |
- |
- |
- |
107 1件: 107 💬 |
25 |
Ccr1 antagonist |
- |
- |
- |
- |
046 1件: 46 💬 |
26 |
Ccx 354 |
- |
- |
- |
- |
046 1件: 46 💬 |
27 |
Ccx 354-c |
- |
- |
- |
- |
046 1件: 46 💬 |
28 |
Ccx-354 |
CCX-354 |
- |
- |
- |
046 1件: 46 💬 |
29 |
Ccx-354-c |
CCX-354 |
- |
- |
- |
046 1件: 46 💬 |
30 |
Ccx140 |
- |
- |
- |
- |
222 1件: 222 💬 |
31 |
Ccx140-b |
- |
- |
- |
- |
222 1件: 222 💬 |
32 |
Ccx168 |
- |
- |
- |
- |
043 6件: 43, 44, 66, 109, 222, 223 💬 |
33 |
Ccx282-b |
- |
- |
- |
- |
096 1件: 96 💬 |
34 |
Ccx354 |
- |
- |
- |
- |
046 1件: 46 💬 |
35 |
Ccx354-c |
- |
- |
- |
- |
046 1件: 46 💬 |
36 |
Dtr melatonin (nih cc pds) |
Melatonin |
1件: D08170 D08170 💬 |
MTNR1A 2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
202 1件: 202 💬 |
37 |
Ganaxolone, spt3162, md 9150000, ccd-1042, mepalon 1042, (3a-hydroxy-3beta-methyl-5a-pregnan-20-one) |
Ganaxolone |
1件: D04300 D04300 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
152 1件: 152 💬 |
38 |
Ganaxolone, spt3162, md 9150000, ccd-1042, mepalon 1042, (3a-hydroxy-3ß-methyl-5a-pregnan-20-one) |
Ganaxolone |
1件: D04300 D04300 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
152 1件: 152 💬 |
39 |
Opl-ccl2-lpm |
- |
- |
- |
- |
066 1件: 66 💬 |
40 |
Pomalidomide (cc-4047 |
Pomalidomide |
1件: D08976 D08976 💬 |
IL6 2件: IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
085 1件: 85 💬 |
41 |
Pomalidomide (cc-4047) |
Pomalidomide |
1件: D08976 D08976 💬 |
IL6 2件: IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
051 1件: 51 💬 |